drugset / Trial / NCT04390685
Prevention of Breast Cancer-related Lymphedma With Tacrolimus
Non-randomizedParallel-groupOpen-labelPrevention
Summary
Breast cancer-related lymphedema is one of the most common and feared consequences of breast cancer treatment. Tacrolimus ointment may prevent lymphedema by inhibition of CD4+T cells.
Timeline
- Start
- 2020-02-26
- Primary completion
- 2022-09
- Completion
- 2022-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Tacrolimus | Small molecule | — | Topical |